Your browser doesn't support javascript.
loading
Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmes.
Aroda, Vanita R; Erhan, Umut; Jelnes, Peter; Meier, Juris J; Abildlund, Morten Tind; Pratley, Richard; Vilsbøll, Tina; Husain, Mansoor.
Afiliação
  • Aroda VR; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Erhan U; Novo Nordisk A/S, Søborg, Denmark.
  • Jelnes P; Novo Nordisk A/S, Søborg, Denmark.
  • Meier JJ; Department of Internal Medicine, Gastroenterology, Hepatology and Diabetology, Augusta Clinic, Bochum, Germany.
  • Abildlund MT; Novo Nordisk A/S, Søborg, Denmark.
  • Pratley R; AdventHealth Translational Research Institute, Orlando, Florida, USA.
  • Vilsbøll T; Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark.
  • Husain M; Ted Rogers Centre for Heart Research, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Diabetes Obes Metab ; 25(5): 1385-1397, 2023 05.
Article em En | MEDLINE | ID: mdl-36700417
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pancreatite / Diabetes Mellitus Tipo 2 / Retinopatia Diabética / Gastroenteropatias Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pancreatite / Diabetes Mellitus Tipo 2 / Retinopatia Diabética / Gastroenteropatias Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article